Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Family Med Prim Care ; 9(9): 4805-4808, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33209804

RESUMEN

INTRODUCTION: Pedagogical constructs such as flipped classroom are used to engage students in the learning process by their active participation. The aim of the present study was to compare the two models of flipped classroom and traditional lecture in training undergraduates in pediatric epilepsy. METHODS: The study was conducted among the 3rd-year undergraduate medical students. They were divided to either of Group I or II. Pediatric epilepsy was taught in two parts (clinical diagnosis and management). Group I received Part A as traditional lecture and Part B as the flipped classroom and the reverse for Group II. The difference in posttest and pretest scores was compared between two groups for each part. RESULTS: There was a significant increase in posttest scores when compared to pretest scores in both the groups. Mean (standard deviation [SD]) difference in scores for epilepsy diagnosis was comparable in Group I (3.33 [2.3]) and Group II (2.46 [2.17]) (P = 0.16). Mean (SD) difference in scores for epilepsy management was significantly higher in Group I (3.41 [2.09]) when compared to Group II (1.30 [1.84]) (P < 0.01). CONCLUSION: Flipped classroom model resulted in better scores than the traditional teaching method for training undergraduates in the management of epilepsy in children. This teaching-learning method could be adopted in training of primary care physicians.

2.
Indian J Pediatr ; 87(7): 547-549, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32052273

RESUMEN

The present cross-sectional study was designed to describe the pattern of comorbid headache among children with epilepsy (CWE) secondary to neurocysticercosis (NCC). Children aged 6 to 14 y (n = 70) already diagnosed with neurocysticercosis on a minimum follow-up of six months were consecutively enroled in the study over a period of four months. Majority of them were boys [41 (58%)] with a mean (SD) age of 9.8 (3.2) y. Headache was reported by 24 (34.2%) children. Only one child among them qualified the diagnosis of migraine as per International Classification of Headache Disorders (ICHD)-3 criteria. The proportion of children with and without headache was comparable among those with active or inactive lesion [p = 0.21]; single or multiple lesions [p = 0.78]; and stages of NCC [p = 0.23]. The proportion of children with headache was similar irrespective of the activity and the number of NCC lesions. This alerts the pediatrician to evaluate the headache and consider migraine among CWE treated for NCC.


Asunto(s)
Epilepsia , Trastornos Migrañosos , Neurocisticercosis , Adolescente , Niño , Estudios Transversales , Epilepsia/epidemiología , Cefalea/epidemiología , Cefalea/etiología , Humanos , Masculino , Neurocisticercosis/complicaciones , Neurocisticercosis/diagnóstico , Neurocisticercosis/epidemiología
4.
Indian J Psychol Med ; 37(1): 90-2, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25722520

RESUMEN

Munchausen syndrome by proxy (MSBP) is emerging as a serious form of child abuse. It is an intentional production of illness in another, usually children by mothers, to assume sick role by proxy. It is poorly understood and a controversial diagnosis. Treatment is very difficult. We present a case of 9-year-old boy brought to Pt. B. D. Sharma, PGIMS, Rohtak, a tertiary care hospital in northern India by his father and paternal uncle with complaints of hematemesis since July 2012. He underwent many invasive procedures until the diagnosis of MSBP was finally considered. The examination of the blood sample confirmed the diagnosis. The child was placed under custody of his mother. The case was reported to social services, which incorporated whole family in the management.

5.
J Pediatr Neurosci ; 9(1): 17-20, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24891896

RESUMEN

OBJECTIVE: The objective of the following study is to assess parent reported quality of life (QOL) in children with epilepsy and to assess the demographic and clinical factors, which influence the QOL in children with epilepsy. STUDY PARTICIPANTS: We consecutively enrolled 40 children aged from 2 years to 14 years with active epilepsy who had undergone a comprehensive evaluation for epilepsy. MATERIALS AND METHODS: Parents were enquired on baseline demographic variables including age, gender, socio-economic status and parental education. Clinical details of epilepsy including the type of epilepsy, seizure frequency were assessed. QOL was evaluated with the parent reported quality of life in childhood epilepsy (QOLCE) questionnaire. RESULTS: A total of 40 children were enrolled of which 55% (22/40) were males and the mean (standard deviation [SD]) age of enrolled children was 10.6 (2.7) years. The majority came from a rural background (80% [32/40]), were from lower (15 [37.5%]) or middle (23 [57.5%]) socio-economic status, with almost half (22 [55%]) of mothers being educated until high school. The overall mean (SD) QOL score was 66.7 (4.83). Lowest mean (SD) scores were observed in self-esteem (45.2 [7.3]) subscale and subscales with higher QOL scores included control/helplessness (82.1 [8.51]), anxiety (81.6 [12.55]) and social stigma (95.0 [11.6]). Parental education, socio-economic status (P = 0.96), frequency of seizure (P = 0.34) or type of epilepsy (P = 0.92) did not significantly affect the overall QOL among children with epilepsy. CONCLUSION: Our study concluded that overall QOL was compromised in Indian children with epilepsy. Demographic factors like parental education, socio-economic status and clinical factors like frequency of seizure or type of seizure did not significantly affect the QOL of epileptic children.

6.
Asian J Psychiatr ; 6(5): 364-8, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24011681

RESUMEN

INTRODUCTION: The presence of depression in patients with diabetes mellitus is reported to be associated with poor glycemic control and an increased risk of diabetic complications. Treatment of depression with selective serotonin reuptake inhibitors (SSRIs) may improve glycemic control and may be beneficial for patients with comorbid depression and diabetes. AIMS AND OBJECTIVE: To study the effect of Escitalopram (SSRI) in patients with diabetes mellitus with comorbid depression and the relationship of treatment response for depression and glycemic control. RESEARCH DESIGN AND METHODS: 40 patients received open-label Escitalopram therapy for up to 12 weeks. Clinical outcome measures included Hamilton Depression rating scale (HAM-D) assessment at 3, 6, and 12 weeks. In addition, fasting and post-prandial plasma glucose level, weight and waist circumference, glycosylated hemoglobin level (HbA1C), lipid profile, renal function test and fundus examination were done before and during Escitalopram therapy. RESULTS: A significant decline in mean HAM-D scores was observed 3 weeks onwards till the end of the study during Escitalopram therapy. There was a corresponding decline in mean fasting and post-prandial plasma glucose level at 6 and 12 weeks respectively and glycosylated hemoglobin level at 12 weeks was observed. CONCLUSION: Escitalopram is effective in treating depression in patients with diabetes mellitus, and has beneficial effects on glycemic control.


Asunto(s)
Citalopram/administración & dosificación , Trastorno Depresivo/tratamiento farmacológico , Diabetes Mellitus/psicología , Inhibidores Selectivos de la Recaptación de Serotonina/administración & dosificación , Administración Oral , Glucemia/metabolismo , Trastorno Depresivo/complicaciones , Diabetes Mellitus/sangre , Diabetes Mellitus/tratamiento farmacológico , Femenino , Hemoglobina Glucada/metabolismo , Humanos , Hipoglucemiantes/administración & dosificación , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
7.
Pathog Glob Health ; 107(4): 210-4, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23816514

RESUMEN

OBJECTIVE: The study was intended to document the clinical profile and treatment outcome of severe malaria caused by Plasmodium vivax (P.vivax) in children hospitalized in a tertiary care centre of northern India. METHODS: This prospective observational study was performed among children admitted with severe malaria at a tertiary care referral hospital of northern India from January 2012 to December 2012. Information was recorded pertaining to clinical symptoms at presentation, examination findings, biochemical and hematological investigation, and treatment outcome. Presence of malarial parasite on thick and thin smears and/or positive parasite lactate dehydrogenase (p-LDH) based rapid malaria antigen test was considered diagnostic of 'malaria'. Based on the etiology, children were categorized into three groups: P.vivax, Plasmodium falciparum (P. falciparum) and mixed infection. Children diagnosed with 'severe malaria' (World Health Organization, 2000), were started on intravenous artesunate followed by artemether-lumefantrine combination. RESULTS: Thirty-five children with a diagnosis of severe malaria were enrolled [18 (51·4%) P. vivax, nine (25·7%) mixed infection, eight (22·8%) P. falciparum]. Clinical features of severe vivax malaria (n = 18) were abnormal sensorium [9 (50%)], multiple seizures [8 (44·4%)], jaundice [5 (27·8%)], severe anaemia [5 (27·8%)], and shock [3 (16·7%)]. Two children [2/18 (11·1%)] infected with P. vivax had died of cerebral malaria, acute respiratory distress syndrome, shock, and metabolic acidosis. The clinical presentation and outcome of severe vivax malaria was found to be similar to severe malaria caused by P. falciparum and mixed infection, except for higher chances of severe anaemia among the children infected with P. falciparum (P = 0·04). CONCLUSION: The present study highlights P. vivax as an increasingly recognized causative agent for severe malaria in children from Rohtak, with similar clinical presentation and outcome to that caused by P. falciparum.


Asunto(s)
Antimaláricos/uso terapéutico , Artemisininas/uso terapéutico , Etanolaminas/uso terapéutico , Fluorenos/uso terapéutico , Malaria Vivax/tratamiento farmacológico , Antígenos de Protozoos/sangre , Combinación Arteméter y Lumefantrina , Artesunato , Sangre/parasitología , Niño , Preescolar , Combinación de Medicamentos , Femenino , Humanos , India , Malaria Vivax/patología , Masculino , Estudios Prospectivos , Centros de Atención Terciaria , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA